Roche increased its hostile tender offer for Genentech Inc. (NYSE: DNA) to $93 per share after its initial bid of $86.50 failed to generate shareholder interest. The stock price surged $9.22 to close at $90.86.
Roche Increases Tender Offer For Genentech
March 06, 2009 at 18:24 PM EST
